Moderna, Inc. — Director's Dealing 2021

Mar 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-03-08

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2021-03-08	Common Stock	M	1478	$12.21	Acquired	11478	Direct
2021-03-08	Common Stock	M	5000	$14.22	Acquired	16478	Direct
2021-03-08	Common Stock	S	1547	$123.48	Disposed	14931	Direct
2021-03-08	Common Stock	S	273	$124.35	Disposed	14658	Direct
2021-03-08	Common Stock	S	1361	$125.68	Disposed	13297	Direct
2021-03-08	Common Stock	S	1350	$126.75	Disposed	11947	Direct
2021-03-08	Common Stock	S	1855	$127.73	Disposed	10092	Direct
2021-03-08	Common Stock	S	2698	$128.62	Disposed	7394	Direct
2021-03-08	Common Stock	S	2312	$129.80	Disposed	5082	Direct
2021-03-08	Common Stock	S	2611	$130.76	Disposed	2471	Direct
2021-03-08	Common Stock	S	2000	$131.83	Disposed	471	Direct
2021-03-08	Common Stock	S	471	$132.91	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-08	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2021-03-08	Stock Option (Right to Buy)	$12.21	M	1478	Disposed	2027-02-23	Common Stock (1478)	Direct
2021-03-08	Stock Option (Right to Buy)	$14.22	M	5000	Disposed	2028-02-28	Common Stock (5000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.88 to $123.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.00 to $124.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.13 to $126.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.14 to $127.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.25 to $128.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.26 to $129.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.31 to $130.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.33 to $131.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.44 to $132.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.46 to $133.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F12: 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F13: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F14: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.